R&D phase duration for a new drug 2019
As of 2019, the average duration of a patent application phase for a new medicine lasted one year. On average, pre-clinical and clinical phases lasted for nine years in total. This statistic chronologically depicts the average duration of research and development, marketing, and patent phases for a new medicine as of 2019.